Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 7, Issue 1
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Psoriatic arthritis
Original research
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis
Online download statistics by month:
Online download statistics by month: January 2021 to January 2021
Abstract
Full
Pdf
Jan 2021
4559
4543
113
Total
4559
4543
113
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF